Commodore Capital LP Rhythm Pharmaceuticals, Inc. Transaction History
Commodore Capital LP
- $1.18 Billion
- Q3 2024
A detailed history of Commodore Capital LP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 650,000 shares of RYTM stock, worth $36.5 Million. This represents 2.89% of its overall portfolio holdings.
Number of Shares
650,000
Previous 1,225,000
46.94%
Holding current value
$36.5 Million
Previous $50.3 Million
32.3%
% of portfolio
2.89%
Previous 4.51%
Shares
5 transactions
Others Institutions Holding RYTM
# of Institutions
191Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$405 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$378 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$359 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$341 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$218 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.13B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...